Project Number ADDF-58 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2022 View Full Project Details for Repairing neurotransmission in Alzheimer's disease and related disorders by targeting caspase-2 Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) m. Synaptic Plasticity/Neuroprotection Researcher and Organization Principal Investigator Ashe, Karen Principal Investigator First Name Karen Principal Investigator Last Name Ashe Awardee Organization University of Minnesota Awardee State Minnesota Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Drug Development Request for Proposals FY Overall Cost $600,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management